292 related articles for article (PubMed ID: 30018256)
1. Breast Cancer Stem Cells.
Crabtree JS; Miele L
Biomedicines; 2018 Jul; 6(3):. PubMed ID: 30018256
[TBL] [Abstract][Full Text] [Related]
2. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
Shima H; Yamada A; Ishikawa T; Endo I
Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
Front Oncol; 2020; 10():452. PubMed ID: 32426267
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
7. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment.
Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL
Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Saeg F; Anbalagan M
Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
[TBL] [Abstract][Full Text] [Related]
10. The Breast Cancer Stem Cells Traits and Drug Resistance.
Zheng Q; Zhang M; Zhou F; Zhang L; Meng X
Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277
[TBL] [Abstract][Full Text] [Related]
11. The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.
Rodriguez D; Ramkairsingh M; Lin X; Kapoor A; Major P; Tang D
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336602
[TBL] [Abstract][Full Text] [Related]
12. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer.
Niu T; Zhang W; Xiao W
Cancer Cell Int; 2021 Jan; 21(1):31. PubMed ID: 33413418
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Stem Cells and Sex Steroid Hormones.
Flores-Ramírez I; Baranda-Avila N; Langley E
Curr Stem Cell Res Ther; 2019; 14(5):398-404. PubMed ID: 30095060
[TBL] [Abstract][Full Text] [Related]
16. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells.
Hwang-Verslues WW; Lee WH; Lee EY
J Mol Biomark Diagn; 2012; Suppl 8():6. PubMed ID: 24977105
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions.
Singh D; Sahoo A
Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38251701
[TBL] [Abstract][Full Text] [Related]
19. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
